T-cell vaccination

T-cell vaccination is immunization with inactivated autoreactive T cells. The concept of T-cell vaccination is, at least partially, analogous to classical vaccination against infectious disease. However, the agents to be eliminated or neutralized are not foreign microbial agents but a pathogenic autoreactive T-cell population. Research on T-cell vaccination so far has focused mostly on multiple sclerosis and to a lesser extent on rheumatoid arthritis, Crohn's disease and AIDS.^[1]^[2]^[3]

References

^ Cohen IR (2001). "T-cell vaccination for autoimmune disease: a panorama". Vaccine. 20 (5–6): 706–10. doi:10.1016/S0264-410X(01)00419-4. PMID 11738733.
^ Hellings N, Raus J, Stinissen P (2004). "T-cell vaccination in multiple sclerosis: update on clinical application and mode of action". Autoimmun Rev. 3 (4): 267–75. doi:10.1016/j.autrev.2003.10.002. PMID 15246022.
^ Zhang J (2002). "T-cell vaccination for autoimmune diseases: immunologic lessons and clinical experience in multiple sclerosis". Expert Rev Vaccines. 1 (3): 285–92. doi:10.1586/14760584.1.3.285. PMID 12901569. S2CID 1270824.

This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.

[1] Cohen IR (2001). "T-cell vaccination for autoimmune disease: a panorama". Vaccine. 20 (5–6): 706–10. doi:10.1016/S0264-410X(01)00419-4. PMID 11738733.

[2] Hellings N, Raus J, Stinissen P (2004). "T-cell vaccination in multiple sclerosis: update on clinical application and mode of action". Autoimmun Rev. 3 (4): 267–75. doi:10.1016/j.autrev.2003.10.002. PMID 15246022.

[3] Zhang J (2002). "T-cell vaccination for autoimmune diseases: immunologic lessons and clinical experience in multiple sclerosis". Expert Rev Vaccines. 1 (3): 285–92. doi:10.1586/14760584.1.3.285. PMID 12901569. S2CID 1270824.

[1]

[2]

[3]